Twist Bioscience (NASDAQ:TWST) reported its Q2 earnings results on Friday, May 5, 2023 at 07:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Twist Bioscience beat estimated earnings by 7.14%, reporting an EPS of $-1.04 versus an estimate of $-1.12.
Revenue was up $12.05 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.39 which was followed by a 18.09% drop in the share price the next day.
Here’s a look at Twist Bioscience’s past performance:
| Quarter | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.13 | -1.25 | -1.31 | -1.28 |
| EPS Actual | -0.74 | -0.99 | -1.08 | -1.13 |
| Revenue Estimate | 54.10M | 57.02M | 51.45M | 45.25M |
| Revenue Actual | 54.24M | 57.31M | 56.11M | 48.13M |
To track all earnings releases for Twist Bioscience visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
